ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,840.86
      -0.32%
      US Tech 100
      19,693.60
      -1.04%
      Dow Jones
      42,884.65
      -0.42%
      Brent Oil
      73.61
      -1.74%
      Bitcoin
      65,702.05
      -0.54%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tarsus Pharmaceuticals Inc (TARS) Quote

      Tarsus Pharmaceuticals Inc

      Tarsus Pharmaceuticals Inc (TARS)

      NASDAQ
      36.815
      0.335
      ( 0.92% )
      Updated: 10:36:42
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      36.815
      Bid
      36.69
      Ask
      36.88
      Volume
      170,325
      36.13 Day's Range 37.20
      12.57 52 Week Range 42.50
      Market Cap
      1.401B
      Previous Close
      36.48
      Open
      36.32
      Last Trade
      1
      @
      36.815
      Last Trade Time
      10:36:53
      Financial Volume
      $ 6,270,731
      VWAP
      36.8163
      Average Volume (3m)
      703,325
      Shares Outstanding
      38,041,737
      Dividend Yield
      -
      PE Ratio
      -10.34
      Earnings Per Share (EPS)
      -3.57
      Revenue
      17.45M
      Net Profit
      -135.89M

      About Tarsus Pharmaceuticals Inc

      Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.tarsusrx.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Tarsus Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TARS. The last closing price for Tarsus Pharmaceuticals was $36.48. Over the last year, Tarsus Pharmaceuticals shares have traded in a share price range of $ 12.57 to $ 42.50.

      Tarsus Pharmaceuticals currently has 38,041,737 shares outstanding. The market capitalization of Tarsus Pharmaceuticals is $1.39 billion. Tarsus Pharmaceuticals has a price to earnings ratio (PE ratio) of -10.34.

      Ask ADVFN Intelligence (AI)

      TARS Latest News

      More News

      FeaturedZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management

      3 hours ago

      Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

      IRVINE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...

      September 25 2024
      GlobeNewswire Inc.

      Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

      IRVINE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...

      August 28 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      August 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

      Generated $40.8 million in XDEMVY® net product sales in the second quarter and $65.5 million year-to-date Delivered more than 37,000 bottles of XDEMVY to patients in the second quarter Delivered...

      August 08 2024
      GlobeNewswire Inc.

      Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

      IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...

      July 29 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 18 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 14 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 14 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      13.0358.984606275933.7837.233.4850154135.22467197CS
      44.88515.299091763231.9337.230.22551821733.67890544CS
      129.78536.20051794327.0337.220.081870332528.445338CS
      260.5651.5586206896636.2542.520.081865515929.9404334CS
      5223.965186.49805447512.8542.512.5767902027.78393018CS
      1568.36529.402460456928.4542.510.800133547324.13204883CS
      26018.515101.17486338818.363.6910.800126643424.64663507CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DRUGBright Minds Biosciences Inc
      $ 7.59
      (204.82%)
      		46.73M
      ZPTAZapata Computing Holdings Inc
      $ 0.1849
      (140.13%)
      		390.27M
      DBGIDigital Brands Group Inc
      $ 0.2157
      (34.98%)
      		68.86M
      GRTSGritstone bio Inc
      $ 0.069199
      (28.15%)
      		231.81M
      WAVEEco Wave Power Global AB
      $ 11.18
      (28.06%)
      		251.59k
      SEELSeelos Therapeutics Inc
      $ 1.25
      (-48.98%)
      		538.6k
      NTBLNotable Labs Ltd
      $ 0.2731
      (-31.73%)
      		1.12M
      YYAIConnexa Sports Technologies Inc
      $ 4.43
      (-26.04%)
      		100.85k
      LGHLWLion Group Holding Ltd
      $ 0.0062
      (-23.46%)
      		123.63k
      AMLIAmerican Lithium Corporation
      $ 0.8575
      (-22.75%)
      		1.87M
      ZPTAZapata Computing Holdings Inc
      $ 0.1849
      (140.13%)
      		390.39M
      GRTSGritstone bio Inc
      $ 0.067
      (24.07%)
      		232.12M
      NVDANVIDIA Corporation
      $ 131.4506
      (-4.79%)
      		109.45M
      DBGIDigital Brands Group Inc
      $ 0.2157
      (34.98%)
      		68.87M
      SQQQProShares UltraPro Short QQQ
      $ 7.18
      (2.72%)
      		48.67M

      TARS Discussion

      View Posts
      Monksdream Monksdream 4 weeks ago
      TARS ride the trend
      👍️0
      Monksdream Monksdream 6 months ago
      TARS over $30
      👍️0

      Your Recent History

      NASDAQ
      TARS
      Tarsus Pharmaceuticals
      Delayed Upgrade Clock